BCL2 and prostate carcinoma: The researchers testified to the synergistic effect of paclitaxel with endemic plant extracts (combination index, CI; ED50<0.41). The combinations, which indicated the synergistic effect, increased the Bax/Bcl-2 ratio by suppressing Bcl-2 gene expression into the prostate cancer cell lines.